Cargando…

Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment

INTRODUCTION: Venous thromboembolism (VTE) is a condition that annually occurs in approximately 1‰ of the world’s population. Patients who have already had a VTE are at elevated risk for a recurrent VTE. Recurrent events increase the risk of long-term sequelae and can be fatal. Adequate secondary pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ten Cate, Vincent, Essers, Brigitte AB, Prins, Martin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Open 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777455/
https://www.ncbi.nlm.nih.gov/pubmed/28495816
http://dx.doi.org/10.1136/bmjopen-2016-015231
_version_ 1783294198606200832
author Ten Cate, Vincent
Essers, Brigitte AB
Prins, Martin H
author_facet Ten Cate, Vincent
Essers, Brigitte AB
Prins, Martin H
author_sort Ten Cate, Vincent
collection PubMed
description INTRODUCTION: Venous thromboembolism (VTE) is a condition that annually occurs in approximately 1‰ of the world’s population. Patients who have already had a VTE are at elevated risk for a recurrent VTE. Recurrent events increase the risk of long-term sequelae and can be fatal. Adequate secondary prophylaxis is thus needed to prevent such events. Patients with VTE are often prone to bleeding, and pharmacological prophylaxis exacerbates bleeding risk. Expert opinions on the optimum duration of secondary prophylaxis in VTE still vary substantially. The existence of treatment guidelines has not led to uniformity of VTE secondary prophylaxis strategies, which means that physicians still adhere to individual risk calculi in determining treatment duration. METHODS AND ANALYSIS: The aim of this study is to establish what factors lie at the root of this variance in VTE secondary prophylactic treatment strategies, and what risk factors are deemed of particular importance in determining the perceived risks and benefits of variable treatment durations. To do this, we created a survey based on a D-efficient and G-efficient balanced experimental vignette design. This protocol covers all aspects of how this survey was set up and how it was implemented. The analysis of the experimental data will be carried out using mixed-effects methods, which are beneficial in scenarios with high interindividual variance and correlated (eg, repeated-measures) responses. We propose the use of maximal random effects structures insofar as possible. ETHICS AND DISSEMINATION: All data are de-identified, and any identifying characteristics of the respondents will not be reported in a final manuscript or elsewhere. A paper describing the expert interviews is currently under peer review. A manuscript that contains the analysis of the results of the experiment described in this protocol is being drafted, and will also be submitted to a peer-reviewed journal.
format Online
Article
Text
id pubmed-5777455
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Open
record_format MEDLINE/PubMed
spelling pubmed-57774552018-01-29 Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment Ten Cate, Vincent Essers, Brigitte AB Prins, Martin H BMJ Open Research Methods INTRODUCTION: Venous thromboembolism (VTE) is a condition that annually occurs in approximately 1‰ of the world’s population. Patients who have already had a VTE are at elevated risk for a recurrent VTE. Recurrent events increase the risk of long-term sequelae and can be fatal. Adequate secondary prophylaxis is thus needed to prevent such events. Patients with VTE are often prone to bleeding, and pharmacological prophylaxis exacerbates bleeding risk. Expert opinions on the optimum duration of secondary prophylaxis in VTE still vary substantially. The existence of treatment guidelines has not led to uniformity of VTE secondary prophylaxis strategies, which means that physicians still adhere to individual risk calculi in determining treatment duration. METHODS AND ANALYSIS: The aim of this study is to establish what factors lie at the root of this variance in VTE secondary prophylactic treatment strategies, and what risk factors are deemed of particular importance in determining the perceived risks and benefits of variable treatment durations. To do this, we created a survey based on a D-efficient and G-efficient balanced experimental vignette design. This protocol covers all aspects of how this survey was set up and how it was implemented. The analysis of the experimental data will be carried out using mixed-effects methods, which are beneficial in scenarios with high interindividual variance and correlated (eg, repeated-measures) responses. We propose the use of maximal random effects structures insofar as possible. ETHICS AND DISSEMINATION: All data are de-identified, and any identifying characteristics of the respondents will not be reported in a final manuscript or elsewhere. A paper describing the expert interviews is currently under peer review. A manuscript that contains the analysis of the results of the experiment described in this protocol is being drafted, and will also be submitted to a peer-reviewed journal. BMJ Open 2017-05-10 /pmc/articles/PMC5777455/ /pubmed/28495816 http://dx.doi.org/10.1136/bmjopen-2016-015231 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Research Methods
Ten Cate, Vincent
Essers, Brigitte AB
Prins, Martin H
Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title_full Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title_fullStr Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title_full_unstemmed Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title_short Determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
title_sort determinants of treatment duration in the prevention of recurrent venous thromboembolism: a protocol for a balanced vignette experiment
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777455/
https://www.ncbi.nlm.nih.gov/pubmed/28495816
http://dx.doi.org/10.1136/bmjopen-2016-015231
work_keys_str_mv AT tencatevincent determinantsoftreatmentdurationinthepreventionofrecurrentvenousthromboembolismaprotocolforabalancedvignetteexperiment
AT essersbrigitteab determinantsoftreatmentdurationinthepreventionofrecurrentvenousthromboembolismaprotocolforabalancedvignetteexperiment
AT prinsmartinh determinantsoftreatmentdurationinthepreventionofrecurrentvenousthromboembolismaprotocolforabalancedvignetteexperiment